Please login to the form below

Not currently logged in
Email:
Password:

lorcaserin

This page shows the latest lorcaserin news and features for those working in and with pharma, biotech and healthcare.

Eisai agrees to pull obesity drug Belviq after safety alert

Eisai agrees to pull obesity drug Belviq after safety alert

The decision to withdraw Belviq (lorcaserin) and once-daily line extension Belviq XR from the US market stems from a clinical trial that was conducted at the request of the FDA ... The study was intended to check whether the drug was associated with any

Latest news

More from news
Approximately 3 fully matching, plus 30 partially matching documents found.

Latest appointments

  • Anthony Zook resigns as Vivus CEO Anthony Zook resigns as Vivus CEO

    This coup was led by investment group First Manhattan Co, which had attempted to replace the entire board of Vivus after Qsymia fell behind rival obesity drug Belviq (lorcaserin) from Arena

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
...
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics